Clinical Trial Update: US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update on US-licensed combined tetanus, diphtheria, and meningococcal vaccines; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Tetanus

Drugs mentioned

• AUS vaccine combination (Tetanus, Diphtheria, Acellular Pertussis) with meningococcal vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acellular Pertussis, Tetanus | Phase 4 | Status: COMPLETED | Results posted: 2017-03-16